Updated: Sep 16, 2019
There are currently a number of active antitrust settlements and lawsuits that fall into the category of “pharmaceutical settlements.” Under these settlements, it is generally alleged that businesses with self-insured health plans overpaid for drugs purchased on behalf of their employees due to artificially inflated and/or stabilized prices. The prices were allegedly manipulated as a result of anti-competitive practices undertaken by the drug manufacturers.
Eligible Item(s) Purchased Date Range Covered Settlement Fund Filing Deadline
Solodyn (antibiotic) 2009 - 2018 $43 million July 31, 2018
Aggrenox (stroke prevention) 2009 - 2017 $54 million Sept 14, 2018
Lidoderm (pain relief patch) 2012 - 2014 $96 million Oct 1, 2018
Next Steps for MCAG Clients
Data is often required to complete your claim for settlements in this category. MCAG can quickly review the process with you so we can easily obtain necessary information from your Pharmacy Benefit Manager (i.e. CVS Caremark, Express Scripts, OptumRX) to pursue current and future pharmaceutical settlements. Should you wish to proceed, please contact an Account Manager at 800.355.0466 or send an email to email@example.com.